After four years, MAPS Founder and Executive Director Rick Doblin, Ph.D., returns to the David Pakman Show to provide an update about the state of psychedelic research, including the results of MAPS’ first Phase 3 trial of MDMA-assisted therapy for PTSD, and share excitement about the wide political range of MAPS supporters.
Originally appearing here.
